chr3-56557250-T-TGGGGTAAGCA

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The NM_001141947.3(CCDC66):​c.11+7_11+16dup variant causes a stop gained, frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.813 in 1,546,866 control chromosomes in the GnomAD database, including 517,371 homozygotes. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.76 ( 44725 hom., cov: 0)
Exomes 𝑓: 0.82 ( 472646 hom. )

Consequence

CCDC66
NM_001141947.3 stop_gained, frameshift

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.359
Variant links:
Genes affected
CCDC66 (HGNC:27709): (coiled-coil domain containing 66) Enables microtubule binding activity. Involved in cilium assembly; microtubule bundle formation; and regulation of protein localization to cilium. Located in several cellular components, including Flemming body; microtubule cytoskeleton; and photoreceptor inner segment. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP6
Variant 3-56557250-T-TGGGGTAAGCA is Benign according to our data. Variant chr3-56557250-T-TGGGGTAAGCA is described in ClinVar as [Benign]. Clinvar id is 402505.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.848 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CCDC66NM_001141947.3 linkuse as main transcriptc.11+7_11+16dup stop_gained, frameshift_variant 1/18 ENST00000394672.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CCDC66ENST00000394672.8 linkuse as main transcriptc.11+7_11+16dup stop_gained, frameshift_variant 1/181 NM_001141947.3 A2A2RUB6-1

Frequencies

GnomAD3 genomes
AF:
0.763
AC:
114724
AN:
150364
Hom.:
44711
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.630
Gnomad AMI
AF:
0.843
Gnomad AMR
AF:
0.783
Gnomad ASJ
AF:
0.826
Gnomad EAS
AF:
0.556
Gnomad SAS
AF:
0.541
Gnomad FIN
AF:
0.837
Gnomad MID
AF:
0.756
Gnomad NFE
AF:
0.854
Gnomad OTH
AF:
0.755
GnomAD4 exome
AF:
0.818
AC:
1142155
AN:
1396384
Hom.:
472646
Cov.:
66
AF XY:
0.812
AC XY:
558958
AN XY:
688646
show subpopulations
Gnomad4 AFR exome
AF:
0.610
Gnomad4 AMR exome
AF:
0.760
Gnomad4 ASJ exome
AF:
0.821
Gnomad4 EAS exome
AF:
0.572
Gnomad4 SAS exome
AF:
0.566
Gnomad4 FIN exome
AF:
0.838
Gnomad4 NFE exome
AF:
0.854
Gnomad4 OTH exome
AF:
0.789
GnomAD4 genome
AF:
0.763
AC:
114785
AN:
150482
Hom.:
44725
Cov.:
0
AF XY:
0.758
AC XY:
55644
AN XY:
73378
show subpopulations
Gnomad4 AFR
AF:
0.629
Gnomad4 AMR
AF:
0.783
Gnomad4 ASJ
AF:
0.826
Gnomad4 EAS
AF:
0.557
Gnomad4 SAS
AF:
0.540
Gnomad4 FIN
AF:
0.837
Gnomad4 NFE
AF:
0.854
Gnomad4 OTH
AF:
0.752

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 1498/2178=68.77% -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs60235683; hg19: chr3-56591278; API